# A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-1-2-open-label-assessment-of-the-safety-tolerability-and-efficacy-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Helen Heussler,Jonathan Cohen,Natalie Silove,Nancy Tich,Marcel O. Bonn‐Miller,Wei Du,Carol O’Neill,Terri Sebree |
| Citations | 105 |
| DOI | 10.1186/s11689-019-9277-x |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jneurodevdisorders.biomedcentral.com/counter/pdf/10.1186/s11689-019-9277-x |
| OpenAlex ID | https://openalex.org/W2965554962 |
| PMID | 31370779 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Helen Heussler](https://scholariq.org/researchers/helen-heussler/)

## Paper journal

- [Journal of Neurodevelopmental Disorders](https://scholariq.org/journals/journal-of-neurodevelopmental-disorders/)

## Paper primary topic

- [Cannabis and Cannabinoid Research](https://scholariq.org/topics/cannabis-and-cannabinoid-research/)

## Paper topics

- [Cannabis and Cannabinoid Research](https://scholariq.org/topics/cannabis-and-cannabinoid-research/)
- [Genetics and Neurodevelopmental Disorders](https://scholariq.org/topics/genetics-and-neurodevelopmental-disorders/)
- [Attention Deficit Hyperactivity Disorder](https://scholariq.org/topics/attention-deficit-hyperactivity-disorder/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.